A pioneering clinical trial led by Dr. Georg Schett at Friedrich-Alexander University in Germany has …
u00a92022u00a0Soledad. Designed and Developed by Penci Design
Category:
Uncategorized
-
-
The U.S. Food and Drug Administration (FDA) has approved Iovance Biotherapeutics’ treatment lifileucel, marketed as …
-
Dana-Farber Cancer Institute and the Broad Institute have launched a new trial to investigate a …
-
The U.S. Food and Drug Administration (FDA) has approved Tukysa (tucatinib) in combination with trastuzumab …
-
A new clinical trial has launched to test a promising treatment for patients with recurrent …
-
Researchers have reported positive early results for acasunlimab, a bispecific T-cell engager targeting PSMA and …
-
A recent study published in Nature Communications has highlighted a promising new treatment approach for …
-
AstraZeneca has revealed early results from its phase 1 trial of AZD1390, a potential first-in-class …
Older Posts
